These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28641766)

  • 1. Amyloid PET in pseudotumoral multiple sclerosis.
    Matías-Guiu JA; Cabrera-Martín MN; Cortés-Martínez A; Pytel V; Moreno-Ramos T; Oreja-Guevara C; Carreras JL; Matías-Guiu J
    Mult Scler Relat Disord; 2017 Jul; 15():15-17. PubMed ID: 28641766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.
    Matías-Guiu JA; Cabrera-Martín MN; Matías-Guiu J; Oreja-Guevara C; Riola-Parada C; Moreno-Ramos T; Arrazola J; Carreras JL
    BMC Neurol; 2015 Nov; 15():243. PubMed ID: 26607782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
    Pietroboni AM; Carandini T; Colombi A; Mercurio M; Ghezzi L; Giulietti G; Scarioni M; Arighi A; Fenoglio C; De Riz MA; Fumagalli GG; Basilico P; Serpente M; Bozzali M; Scarpini E; Galimberti D; Marotta G
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):280-287. PubMed ID: 30343433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal partial volume correction: Application to [
    Grecchi E; Veronese M; Bodini B; García-Lorenzo D; Battaglini M; Stankoff B; Turkheimer FE
    J Cereb Blood Flow Metab; 2017 Dec; 37(12):3803-3817. PubMed ID: 28569617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seven-Tesla Magnetization Transfer Imaging to Detect Multiple Sclerosis White Matter Lesions.
    Chou IJ; Lim SY; Tanasescu R; Al-Radaideh A; Mougin OE; Tench CR; Whitehouse WP; Gowland PA; Constantinescu CS
    J Neuroimaging; 2018 Mar; 28(2):183-190. PubMed ID: 28944575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Carotenuto A; Giordano B; Dervenoulas G; Wilson H; Veronese M; Chappell Z; Polychronis S; Pagano G; Mackewn J; Turkheimer FE; Williams SCR; Hammers A; Silber E; Brex P; Politis M
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):366-378. PubMed ID: 31637481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Carvalho RHF; Real CC; Cinini S; Garcez AT; Duran FLS; Marques FLN; Mello LE; Busatto Filho G; de Vries EFJ; de Britto LRG; Buchpiguel CA; de Paula Faria D
    Mult Scler Relat Disord; 2019 Oct; 35():108-115. PubMed ID: 31362166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis.
    Zeydan B; Lowe VJ; Schwarz CG; Przybelski SA; Tosakulwong N; Zuk SM; Senjem ML; Gunter JL; Roberts RO; Mielke MM; Benarroch EE; Rodriguez M; Machulda MM; Lesnick TG; Knopman DS; Petersen RC; Jack CR; Kantarci K; Kantarci OH
    Mult Scler; 2018 May; 24(6):739-749. PubMed ID: 28474977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.
    Colasanti A; Guo Q; Muhlert N; Giannetti P; Onega M; Newbould RD; Ciccarelli O; Rison S; Thomas C; Nicholas R; Muraro PA; Malik O; Owen DR; Piccini P; Gunn RN; Rabiner EA; Matthews PM
    J Nucl Med; 2014 Jul; 55(7):1112-8. PubMed ID: 24904112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.
    Giannetti P; Politis M; Su P; Turkheimer FE; Malik O; Keihaninejad S; Wu K; Waldman A; Reynolds R; Nicholas R; Piccini P
    Brain; 2015 Jan; 138(Pt 1):110-9. PubMed ID: 25416179
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Datta G; Colasanti A; Kalk N; Owen D; Scott G; Rabiner EA; Gunn RN; Lingford-Hughes A; Malik O; Ciccarelli O; Nicholas R; Nei L; Battaglini M; De Stefano N; Matthews PM
    J Nucl Med; 2017 Sep; 58(9):1477-1482. PubMed ID: 28302760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Dimensional Shape and Surface Features Distinguish Multiple Sclerosis Lesions from Nonspecific White Matter Disease.
    Newton BD; Wright K; Winkler MD; Bovis F; Takahashi M; Dimitrov IE; Sormani MP; Pinho MC; Okuda DT
    J Neuroimaging; 2017 Nov; 27(6):613-619. PubMed ID: 28488804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
    Sucksdorff M; Matilainen M; Tuisku J; Polvinen E; Vuorimaa A; Rokka J; Nylund M; Rissanen E; Airas L
    Brain; 2020 Dec; 143(11):3318-3330. PubMed ID: 33006604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction.
    Brendel M; Högenauer M; Delker A; Sauerbeck J; Bartenstein P; Seibyl J; Rominger A;
    Neuroimage; 2015 Mar; 108():450-9. PubMed ID: 25482269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid- and FDG-PET in sporadic Creutzfeldt-Jakob disease: Correlation with pathological prion protein in neuropathology.
    Matías-Guiu JA; Guerrero-Márquez C; Cabrera-Martín MN; Gómez-Pinedo U; Romeral M; Mayo D; Porta-Etessam J; Moreno-Ramos T; Carreras JL; Matías-Guiu J
    Prion; 2017 May; 11(3):205-213. PubMed ID: 28509609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new integrated dual time-point amyloid PET/MRI data analysis method.
    Cecchin D; Barthel H; Poggiali D; Cagnin A; Tiepolt S; Zucchetta P; Turco P; Gallo P; Frigo AC; Sabri O; Bui F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2060-2072. PubMed ID: 28674847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amyloid and small vessel disease on white matter network disruption.
    Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
    J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of in vivo
    Bucerius J; Barthel H; Tiepolt S; Werner P; Sluimer JC; Wildberger JE; Patt M; Hesse S; Gertz HJ; Biessen EAL; Mottaghy FM; Sabri O
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1119-1128. PubMed ID: 28321471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS.
    de Paula Faria D; de Vries EF; Sijbesma JW; Dierckx RA; Buchpiguel CA; Copray S
    Neuroimage; 2014 Feb; 87():395-402. PubMed ID: 24188813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.